Kura Oncology Inc.

Kura Oncology Inc. is a biopharmaceutical company focused on the discovery and development of precision medicines for the treatment of cancer. The company's research and development efforts are centered on identifying and targeting specific molecular pathways implicated in cancer growth and progression. Kura Oncology aims to develop novel therapies that selectively inhibit these pathways, offering the potential for more effective and less toxic cancer treatments. The company operates in the biotechnology and pharmaceutical sector, contributing to advancements in targeted cancer therapies. Their pipeline includes investigational drugs designed to address unmet medical needs in various cancer types, reflecting a commitment to improving patient outcomes through innovative scientific approaches. Kura Oncology is publicly traded, allowing investors to participate in the company's growth and development as it strives to bring groundbreaking cancer treatments to market.